Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07786506 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07786506 · ClinicalTrials.gov record · last posted 2026-08-26

Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis

Study acronym: TMS-SPASMS
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-08-10
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Spasticity and neuropathic pain are frequent and disabling symptoms of multiple sclerosis. Intermittent theta-burst stimulation (iTBS) is a non-invasive neuromodulation technique that may modulate cortical and corticospinal excitability and thereby improve motor symptoms and pain. This randomized, parallel-group, sham-controlled, assessor-blinded study will evaluate the clinical efficacy of active iTBS compared with sham stimulation in adults with multiple sclerosis and clinically significant lower-limb spasticity and pain. Participants will receive five stimulation sessions over one week. Spasticity, pain, patient-reported outcomes, and the electrophysiological H/M ratio will be assessed at baseline and at Weeks 2 and 4 after the intervention.
Trial Details
NCT Number NCT07786506
Lead Sponsor Comenius University
Conditions Multiple Sclerosis, Muscle Spasticity, Neuropathic Pain
Enrollment 40 participants
Start Date 2026-08-10
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-26